ストックスクリーナーアプリを入手
9.85
6.95%
0.64
プレマーケット:
9.85
前日終値:
$9.21
開ける：
$9.25
24時間の取引高:
1.53M
Relative Volume:
0.84
時価総額：
$833.72M
収益：
-
当期純損益:
$-43.16M
株価収益率:
-17.91
EPS:
-0.55
ネットキャッシュフロー:
$-29.31M
1週間 パフォーマンス:
-5.92%
1か月 パフォーマンス:
+14.14%
6か月 パフォーマンス:
+79.74%
1年 パフォーマンス:
+62.81%
1日の値動き範囲:
$9.10
$9.85
1週間の範囲:
$8.97
$11.68
52週間の値動き範囲:
$3.25
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
名前
Anavex Life Sciences Corporation
セクター
電話
844-689-3939
住所
630 5TH AVENUE, NEW YORK
AVXL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
9.85 | 833.72M | 0 | -43.16M | -29.31M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-12-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | 開始されました | Berenberg | Buy |
| 2021-09-23 | 開始されました | BTIG Research | Buy |
| 2020-12-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-28 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-02-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-18 | 開始されました | Janney | Buy |
| 2018-05-16 | 再開されました | Maxim Group | Buy |
| 2018-03-08 | 開始されました | ROTH Capital | Buy |
| 2018-02-13 | 繰り返されました | Maxim Group | Buy |
| 2017-09-29 | 再開されました | Noble Financial | Buy |
| 2017-02-07 | 開始されました | Noble Financial | Buy |
| 2016-03-29 | 開始されました | FBR Capital | Outperform |
すべてを表示
Anavex Life Sciences Corporation (AVXL) 最新ニュース
Long-Term investors in shares of Anavex Life Sciences Corp. - openPR
Best Momentum Stocks to Buy for January 21st - Yahoo Finance
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from HC Wainwright - MarketBeat
New Strong Buy Stocks for January 21st - Yahoo Finance
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz - MSN
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Up 9.4%What's Next? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Shares Down 6.3%Time to Sell? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Shares Up 9.4%Here's Why - MarketBeat
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer's Disease - The Manila Times
Anavex's Oral Alzheimer's Drug Shows Breakthrough 36% Disease Slowdown in Phase 3 Trial - StockTitan
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stock Holdings Raised by Barclays PLC - MarketBeat
Barclays PLC Acquires 64,101 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Dru - Asianet Newsable
Anavex Life Sciences: Pioneering Precision Medicine for CNS Disorders - Big News Network
Anavex Life Sciences (NASDAQ:AVXL) Receives “Buy” Rating from D. Boral Capital - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Receives Buy Rating from D. Boral Capital - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) vs. Pluri (NASDAQ:PLUR) Critical Comparison - Defense World
The Misconceptions About Anavex Life Sciences' Blarcamesine Phase 2b/3 Trial In Alzheimer's Disease - Seeking Alpha
Commit To Buy Anavex Life Sciences Corp At $7, Earn 28.6% Using Options - Nasdaq
Jane Street Group LLC Sells 119,531 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat
Jane Street Group LLC Trims Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 11.3%What's Next? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Trading 6.3% HigherStill a Buy? - MarketBeat
Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Anavex Life Sciences to Present at JP Morgan Healthcare Conference 2025: Focus on Neurological Breakthroughs - StockTitan
Anavex Life Sciences (NASDAQ:AVXL) Shares Gap UpShould You Buy? - MarketBeat
Anavex Life Sciences Corp. (NASDAQ:AVXL) Short Interest Up 5.7% in December - Defense World
Franklin Resources Inc. Boosts Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Short Interest in Anavex Life Sciences Corp. (NASDAQ:AVXL) Expands By 5.7% - MarketBeat
Geode Capital Management LLC Increases Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Geode Capital Management LLC Increases Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat
Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year? - Yahoo Finance
Barclays PLC Boosts Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by Barclays PLC - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 7.6%What's Next? - MarketBeat
All You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Buy - Yahoo Finance
HC Wainwright Issues Positive Estimate for AVXL Earnings - MarketBeat
HC Wainwright Has Optimistic Outlook of AVXL Q1 Earnings - Defense World
Anavex Life Sciences: Short-Squeeze Target Gains Traction - Investing.com
Anavex Life Sciences: Jumping In On Time Ahead Of An Early Alzheimer's Decision - Seeking Alpha
Anavex Life Sciences (NASDAQ:AVXL) Price Target Raised to $42.00 at HC Wainwright - Defense World
Anavex Life Sciences (NASDAQ:AVXL) vs. Autolus Therapeutics (NASDAQ:AUTL) Head-To-Head Analysis - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Trading Up 6.9% After Analyst Upgrade - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Up 6.9% After Analyst Upgrade - MarketBeat
Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday - Benzinga
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
H.C. Wainwright highlights blarcamesine’s potential, raises Anavex stock target By Investing.com - Investing.com South Africa
Anavex Life Sciences Faces Manufacturing Challenges Impacting Product Launch and Financial Stability - Yahoo Finance
We're Interested To See How Anavex Life Sciences (NASDAQ:AVXL) Uses Its Cash Hoard To Grow - Simply Wall St
State Street Corp Sells 674,409 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Sold by State Street Corp - MarketBeat
Anavex Life Sciences Corporation (AVXL) 財務データ
収益
当期純利益
現金流量
EPS
4.81%
大文字化:
|
ボリューム (24 時間):